| Scott S Petty, MD | |
|
1777 E Clark St, Suite 330, Pocatello, ID 83201-3357 | |
| (208) 233-1033 | |
| Not Available |
| Full Name | Scott S Petty |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 1777 E Clark St, Pocatello, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881754901 | NPI | - | NPPES |
| 0000100000107 | Other | BLUE SHIELD | |
| 43257 | Other | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | M4325 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Scott S Petty, MD 1777 E Clark St, Suite 330, Pocatello, ID 83201-3357 Ph: (208) 233-1033 | Scott S Petty, MD 1777 E Clark St, Suite 330, Pocatello, ID 83201-3357 Ph: (208) 233-1033 |
News Archive
Joslin scientists report the first generation of human induced pluripotent stem cells from patients with an uncommon form of diabetes, maturity onset diabetes of the young (MODY). These cells offer a powerful resource for studying the role of genetic factors in the development of MODY and testing potential treatments.
MedImmune announced today that interim data from human studies of its nasal spray vaccine for the 2009 novel Influenza A (H1N1) virus demonstrate a similar clinical profile in children and adults 2 to 49 years of age as previously studied seasonal formulations of the vaccine.
In a new bioRxiv study, authors identified a isoform of ACE2 (designated as deltaACE2 or dACE2) receptor, shown to be induced in various human cell types.
Data from a new study show that patients with Hepatitis C virus (HCV) taking direct-acting antiviral treatments (DAAs), who have previously fought off hepatocellular carcinoma (HCC), the most common form of liver cancer,1 had a 'high rate' of re-developing their illness.
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge. A novel nanoparticle-based approach that enables more efficient delivery of siRNA drugs is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
› Verified 9 days ago
Christian F. Schmutz, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1350 Baldy Ave Ste A, Pocatello, ID 83201 Phone: 208-346-7500 Fax: 208-346-7501 | |
Dr. Robert Michael Kennedy, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 777 Hospital Way, G15, Pocatello, ID 83201 Phone: 208-239-2722 Fax: 208-239-3759 | |
Dr. Kathleen Anne Erwin, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-239-2571 Fax: 208-239-3665 | |
Dr. Mary Elizabeth Gerard, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 333 N 18th Ave Ste B4, Pocatello, ID 83201 Phone: 208-232-2233 Fax: 208-232-2299 | |
Dr. William Hazle, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 500 S 11th Ave, Pocatello, ID 83201 Phone: 972-420-8345 Fax: 972-420-7770 | |
Richard D Karem, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-239-2722 Fax: 208-239-3759 |